Amgen Shares Boosted by JB Capital LLC

Institutional investor increases stake in biotech giant by over 360%

Apr. 5, 2026 at 10:07am

Got story updates? Submit your updates here. ›

JB Capital LLC, an investment management firm, significantly increased its position in Amgen Inc. (NASDAQ:AMGN) during the fourth quarter of 2025. The firm now owns 52,941 shares of the medical research company's stock, up from just 11,467 shares previously, representing a 361.7% increase in its holdings.

Why it matters

Amgen is one of the world's largest independent biotechnology companies, with a focus on developing innovative medicines for serious illnesses. The substantial increase in JB Capital's stake suggests the firm sees significant upside potential in Amgen's stock and confidence in the company's future growth prospects.

The details

According to a recent SEC filing, JB Capital LLC now owns 52,941 shares of Amgen stock, making it the 26th largest position in the firm's portfolio. The increased investment represents 0.7% of JB Capital's total assets under management. Amgen's stock has seen strong performance over the past year, rising over 15% as the company continues to advance its pipeline of novel therapies.

  • JB Capital LLC filed its latest 13F report with the SEC on April 5, 2026, disclosing the increased Amgen position.
  • The firm acquired the additional 41,474 Amgen shares during the fourth quarter of 2025.

The players

JB Capital LLC

An investment management firm that has significantly increased its stake in Amgen Inc.

Amgen Inc.

A global biotechnology company focused on developing innovative medicines for serious illnesses.

Got photos? Submit your photos here. ›

The takeaway

The substantial increase in JB Capital's Amgen holdings suggests the firm sees strong long-term potential in the biotech company. As Amgen continues to advance its drug pipeline and navigate the evolving pharmaceutical landscape, investors will be closely watching to see if other institutional players follow suit and boost their positions in the stock.